Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Grabbe

Showing results (271-280 of 325) with videos related to

Pageof 33
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 17, 2022
S1-Leitlinie: Kaposi-SarkomStefan Esser, Helmut Schöfer, Christian Hoffmann, et al.
Cellular Immunology|October 11, 2016
Past, present and future of immunology in MainzAri Waisman, Nadine Hövelmeyer, Andreas Diefenbach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 3, 2022
S1 Guidelines for the Kaposi SarcomaStefan Esser, Helmut Schöfer, Christian Hoffmann, et al.
NPJ Vaccines|June 22, 2023
Author Correction: Dithranol as novel co-adjuvant for non-invasive dermal vaccinationJulian Sohl, Ann-Kathrin Hartmann, Jennifer Hahlbrock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2009
Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanomaAxel Hauschild, Michael Weichenthal, Knuth Rass, et al.
Basic Research in Cardiology|September 25, 2013
CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunctionMichael Hausding, Kerstin Jurk, Steffen Daub, et al.
Journal of Thrombosis and Haemostasis : JTH|September 26, 2022
Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammationMaria Isabel Fleischer, Nadine Röhrig, Verena K Raker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanomaAxel Hauschild, Sanjiv S Agarwala, Uwe Trefzer, et al.
JCI Insight|November 8, 2022
Impaired Treg-DC interactions contribute to autoimmunity in leukocyte adhesion deficiency type 1Tanja Klaus, Alicia S Wilson, Elisabeth Vicari, et al.
Cells|July 27, 2022
β2 Integrins on Dendritic Cells Modulate Cytokine Signaling and Inflammation-Associated Gene Expression, and Are Required for Induction of Autoimmune EncephalomyelitisMonika Bednarczyk, Vanessa Bolduan, Maximilian Haist, et al.
Pageof 33

Showing results (271-280 of 325) with videos related to

Sort By:
Pageof 33
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 17, 2022
S1-Leitlinie: Kaposi-SarkomStefan Esser, Helmut Schöfer, Christian Hoffmann, et al.
Cellular Immunology|October 11, 2016
Past, present and future of immunology in MainzAri Waisman, Nadine Hövelmeyer, Andreas Diefenbach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 3, 2022
S1 Guidelines for the Kaposi SarcomaStefan Esser, Helmut Schöfer, Christian Hoffmann, et al.
NPJ Vaccines|June 22, 2023
Author Correction: Dithranol as novel co-adjuvant for non-invasive dermal vaccinationJulian Sohl, Ann-Kathrin Hartmann, Jennifer Hahlbrock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2009
Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanomaAxel Hauschild, Michael Weichenthal, Knuth Rass, et al.
Basic Research in Cardiology|September 25, 2013
CD40L contributes to angiotensin II-induced pro-thrombotic state, vascular inflammation, oxidative stress and endothelial dysfunctionMichael Hausding, Kerstin Jurk, Steffen Daub, et al.
Journal of Thrombosis and Haemostasis : JTH|September 26, 2022
Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammationMaria Isabel Fleischer, Nadine Röhrig, Verena K Raker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanomaAxel Hauschild, Sanjiv S Agarwala, Uwe Trefzer, et al.
JCI Insight|November 8, 2022
Impaired Treg-DC interactions contribute to autoimmunity in leukocyte adhesion deficiency type 1Tanja Klaus, Alicia S Wilson, Elisabeth Vicari, et al.
Cells|July 27, 2022
β2 Integrins on Dendritic Cells Modulate Cytokine Signaling and Inflammation-Associated Gene Expression, and Are Required for Induction of Autoimmune EncephalomyelitisMonika Bednarczyk, Vanessa Bolduan, Maximilian Haist, et al.
Pageof 33